This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Objectives
The long-term prognostic role of postoperative atrial fibrillation (POAF) on cardiovascular outcomes in patients undergoing cardiac surgery is uncertain. We aimed to investigate the impact of new-onset POAF on mid-term adverse cardiovascular events after coronary artery bypass graft (CABG) surgery.
Methods
This was a retrospective cohort study of patients who underwent isolated CABG without a preoperative history of atrial fibrillation/flutter. POAF was defined as episodes of AF lasting ≥30 seconds during the hospitalization period. The effect of POAF on mid-term all-cause mortality and cerebrovascular accidents/transient ischaemic attacks (CVA/TIA) was assessed using a Cox proportional hazard regression model in a competing risk setting. Additional analyses were performed on patients surviving an event-free early postoperative period (i.e. within 30 postoperative days after the index surgery).
Results
A total of 9,310 patients were followed for a median duration of 48.7 months. New-onset POAF was associated with an increased risk of mid-term all-cause mortality (HR = 1.648, 95% CI: 1.402–1.937; p < 0.001) and CVA/TIA (Subdistribution-HR = 1.635, 1.233–2.167; p = 0.001). After excluding patients who died during the early postoperative period, POAF remained significantly associated with higher late all-cause mortality (HR = 1.518, 1.273–1.811; p < 0.001). However, the risk of late CVA/TIA in patients who survived the early postoperative period without having a stroke was similar between those with and without POAF (Subdistribution-HR = 1.174, 0.797–1.729; p = 0.418).
Conclusions
New-onset POAF after CABG is associated with an increased risk of mid-term overall mortality and stroke. However, late stroke risk is likely similar between patients with and without POAF who survive an event-free early postoperative period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.